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and Plasmodium vivax on naïve cell-mediated 
immunity
Setthakit Chitsanoor1, Sangdao Somsri2, Panyu Panburana3, Mathirut Mungthin4, Ratawan Ubalee5, 
Maliwan Emyeam1, Somchai Jongwutiwes6, Jetsumon Sattabongkot7 and Rachanee Udomsangpetch8,9* 
Abstract 
Background: To date, human peripheral blood mononuclear cells (PBMCs) have been used mainly in immune 
stimulation assays and the interpretation of data can be influenced by the previous immunological history of donors 
and cross reactivity with other infectious agents. Resolving these limitations requires an alternative in vitro model to 
uncover the primary response profiles.
Methods: A novel in vitro model of mononuclear cells (MNCs) generated from haematopoietic stem cells (HSCs) was 
developed and these cells were then co-cultured with various antigens from Plasmodium falciparum and Plasmodium 
vivax to investigate the response of naïve immune cells to malaria antigens by flow cytometry.
Results: In vitro stimulation of naïve lymphocytes showed that CD4+ and CD8+ T lymphocytes were significantly 
reduced (P < 0.01) by exposure to lysates of infected erythrocytes or intact erythrocytes infected with P. falciparum. 
The depletion was associated with the expression of CD95 (Fas receptor) on the surface of T lymphocytes. Maturation 
of T lymphocytes was affected differently, showing elevated CD3+CD4+CD8+ and CD3+CD4−CD8− T lymphocytes 
after stimulation with cell lysates of P. falciparum and P. vivax, respectively. In addition, antigen presenting monocytes 
and dendritic cells derived from haematopoietic stem cells showed impaired HLA-DR expression as a consequence of 
exposure to different species of malaria parasites.
Conclusion: These results suggest that naïve mononuclear cells differentiated in vitro from HSCs could provide a 
valid model for the assessment of immunity. P. falciparum and P. vivax malaria parasites could modulate various popu-
lations of immune cells starting from newly differentiated mononuclear cells.
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Background
To date, research on adaptive immunity has been 
restricted to the use of peripheral blood mononuclear 
cells (PBMCs) as an in  vitro model. However, some of 
these PBMCs are either already committed, or have 
been primed with unknown epitopes from previously 
encountered microbes. Given this phenomenon, there 
might be a number of factors leading to misinterpreta-
tion of results, particularly when cross reactivity is con-
cerned [1, 2]. Lymphocytes circulating in the peripheral 
blood could have already committed to a vast number of 
non-self-antigens derived mostly from microbial prod-
ucts before being recruited into the experiment. A study 
in 2004 by Bisset and colleagues [3] supported this the-
ory, and showed that less than half CD4+ cells, and less 
than a quarter CD8+ T lymphocytes in the peripheral 
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blood remained naïve. Consequently, several diseases 
have shown cross reactivity with malaria, i.e. schistoso-
miasis [4, 5], leishmaniasis, toxoplasmosis, and Chagas’ 
disease [6].
Resolving these limitations requires an alternative 
in vitro model such as newly produced immune cells to 
uncover primary response profiles. However, there is lit-
tle information on the in  vitro application of mononu-
clear cells (MNCs) derived from haematopoietic stem 
cells (HSCs) for research in this area. This study estab-
lishes a novel in vitro model focusing on the use of naïve 
T lymphocytes in stimulation assays. Additionally, the 
system uses newly differentiated immune cells derived 
from cord blood-HSCs to verify the modulatory roles of 
Plasmodium falciparum and Plasmodium vivax in the 
manipulation of naïve immune cells without the interfer-
ence of prior donor immunological exposure.
Methods
Isolation of cord blood mononuclear cells
Ten samples of umbilical cord blood of normal full-term 
newborns obtained from Ramathibodi Hospital following 
informed consent (MURA2014/400 approved by Ethical 
Committee of Research on Human Beings from Ram-
athibodi Hospital, Faculty of Medicine, Mahidol Uni-
versity, Bangkok, Thailand) were used to isolate HSCs. 
Between 50 and 70 ml of cord blood was collected into 
blood bags containing 30  ml of CPDA-1 anticoagulant 
[Kawasumi Laboratories (Thailand) Co Ltd]. Cord blood 
samples were overlaid on Lymphoprep™ solution (Axis 
Shield PoC, Oslo, Norway) at a 1:1 ratio by volume and 
centrifuged (Kubota, Tokyo, Japan) at 1200×g, 20 °C for 
30  min. The interface layer containing the cord blood 
mononuclear cells (CBMNs) was collected and washed 
twice with cold PBS buffer containing 2 mM EDTA. Via-
bility of isolated cells was assessed using the trypan blue 
exclusion method.
Isolation of CD34+ haematopoietic stem cells (HSCs)
HSCs were isolated from CBMNs with a CD34 isola-
tion kit and Mini-MACS columns (Miltenyi Biotech, 
Germany) according to the manufacturer’s protocol. 
Briefly, 1 ×  108 CBMCs were suspended in 500  µl cold 
PBS containing 2  mM EDTA and 0.5% fetal calf serum. 
The cell suspensions were incubated at 4  °C, for 30 min 
with 100 µl of each FcR blocking reagent and anti-CD34 
antibody-conjugated magnetic microbeads (clone: 
QBEND/10). Subsequently, the cells were washed with 
cold PBS buffer to remove unbound anti-CD34 antibod-
ies and loaded onto an LS column (Miltenyi Biotech, 
Germany). The column was rinsed with PBS buffer to 
remove non-specific cells. The retained CD34+ cells were 
eluted from the column with PBS buffer and centrifuged 
at 800×g for 10 min at 4  °C and the resulting cell pellet 
was re-suspended in StemlineII™ medium, cells were 
counted and cultured.
Cultivation and differentiation of HSCs derived 
from CBMNs (HSC‑derived MNCs)
The isolated CD34+ haematopoietic stem cells were cul-
tured according to an established protocol [7]. Briefly, 
5 × 105 cell/ml of CD34+ cells were cultured in 12-well 
tissue culture plates (Costar®, Corning Inc, NY, USA) 
using StemlineII™ medium (Sigma-Aldrich Corp, MI, 
USA) supplemented with 50  ng/ml of stem cell factor 
(Sigma-Aldrich Corp), 10 ng/ml of IL-3 (PeproTech Asia, 
Rehovot, Israel), 100  µg/ml transferrin (Sigma-Aldrich 
Corp) and 100 µg/ml of humulin (Sigma-Aldrich Corp). 
CD34+ HSCs were incubated at 37  °C in a humidified 
atmosphere with 5% CO2 and half volumes of medium 
were replaced with fresh complete medium every three 
days. Cell number and viability were assessed after five 
and ten days of cultivation by the trypan blue exclusion 
method. On day 10 of cultivation, cell surface markers of 
all mononuclear cells were determined by flow cytomet-
ric analysis (FACScan, Becton–Dickinson, Oxford, UK) 
and cells were morphologically examined after Giemsa 
staining. Ten days old HSC-derived MNCs were used in 
co-cultivation with malaria antigens in all assays.
Cultivation of parasites and antigen preparations
Antigens used in this study were prepared from two 
sources of human malaria parasites. Plasmodium falcipa-
rum parasites were obtained from in vitro cultivation of 
TM267 laboratory strain maintained in group O human 
erythrocytes from healthy donors by in vitro cultivation, 
using RPMI-1640 medium (Gibco, Carlsbad, CA. USA) 
supplemented with 10% human serum. The parasites 
were incubated at 37 °C in a humidified atmosphere with 
5% CO2 in air, starting from ring stages until most of the 
P. falciparum parasites entered mature schizont stages.
Plasmodium vivax parasites were isolated from blood 
of 10 P. vivax-infected patients (Ethical Approvals 
WRAIR#1308, MU-IRB 2009/346.2711). Briefly, blood 
samples were filtered through Plasmodipur® filters (Euro-
Diagnostic B.V., The Netherlands) to deplete leukocytes. 
The resulting P. vivax-infected blood were washed twice 
with McCoy 5A medium (Gibco) by centrifugation at 
800×g, 4  °C for 5  min and cultured at 5% haematocrit 
in McCoy’s 5A medium supplemented with 25% human 
AB-serum. The parasites were kept at 37 °C in a humidi-
fied atmosphere with 5% CO2 in air for 24–30 h (depend-
ing on the age of the starting parasites) until most of the 
P. vivax parasites entered mature schizont stages.
Two types of antigen preparations, intact infected 
erythrocytes and parasitized cell lysates, were prepared 
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from both species. Schizont stage parasites were isolated 
by gradient centrifugation at 1200×g, 4  °C for 30  min 
with 60% Percoll® for P. falciparum infected erythro-
cytes, and 45% Percoll® for P. vivax infected erythrocytes 
to enrich the parasite. Plasmodium falciparum-infected 
erythrocytes (PfIEs) and P. vivax-infected erythrocytes 
(PvIEs) in the interface layer between medium and Per-
coll® were collected and washed twice by centrifuga-
tion at 800×g, 4 °C for 5 min with cold RPMI-1640. The 
resulting PfIEs and PvIEs were counted and used to 
stimulate the HSC-derived MNCs as described below. 
For the parasite lysates, the same batch pellets of the 
PfIEs and PvIEs were stored at −70 °C without any cry-
opreservative agent and twice freeze–thawed for use as 
whole malaria infected erythrocyte lysates. Uninfected 
erythrocyte controls were prepared from erythrocytes of 
healthy donor used in the P. falciparum parasite culture 
by repeating the same protocol as that used for infected 
erythrocytes as described above.
Stimulation of HSC‑derived MNCs with malaria antigens
On day 10 of cultivation, HSC-derived MNCs from each 
cord blood sample were individually co-cultured with 
the different malaria antigens, i.e. intact infected eryth-
rocytes and whole parasite infected erythrocyte lysates 
from both P. falciparum and P. vivax (MNCs: anti-
gens = 1:5). Stimulation with intact uninfected erythro-
cyte (1:5) and whole uninfected erythrocyte lysate (1:5) 
were used as baseline controls for the leukocyte response. 
Phytohemagglutinin-A (PHA) (5  µg/ml) was used for 
validating the activity of T lymphocytes for mitogenic 
response. On day 2 or day 4 after stimulation, the HSC-
derived MNCs were harvested for phenotypic characteri-
zation by flow cytometry (FACScan).
Phenotypic characterization and expression of death 
receptor (CD95)
Phenotyping of the cells was performed by three-colour 
flow cytometry (FACScan). Stimulated HSC-derived 
MNCs (1 ×  105 cell) from each condition were labeled 
with fluorescent, dye-conjugated monoclonal antibodies 
to define various populations of cells including T lym-
phocytes (anti-CD3-PECy5, CD4-PE and CD8-FITC), 
monocytes (anti-CD14-PE and HLA-DR-PECy5), den-
dritic cells (anti-CD40-FITC, and HLA-DR-PECy5), 
B lymphocytes (anti-CD19-FITC), NK and NKT cells 
(anti-CD3-PE and CD56-FITC), HSCs (anti-CD34-
PE and Lin-FITC) and expression of death receptor 
(anti-CD3-PE, anti-CD4-FITC, anti-CD8-FITC and anti-
CD95- PECy5) (eBioscience, San Diego, CA, USA; and 
Miltenyi Biotech, Germany for anti-CD34-PE) (details of 
antibodies used can be found in Additional file 1). After 
staining, the cells were washed with PBS pH 7.4 and fixed 
with 1% paraformaldehyde in PBS. The analysis was per-
formed using the CellQuest software (Becton–Dickinson, 
San Jose, CA, USA). The mononuclear cells were gated by 
that excludes those events with low FSC and high SSC, 
for exclusion of debris and dead cells from the analysis.
Statistical analyses
The data are represented as fold change of population 
and analysed by the GraphPad Prism (version 6.0, San 
Diego, CA, USA) and SPSS (version 18.0, Chicago, IL, 
USA) programs. Statistical significance was determined 
by one-way analysis of variance (ANOVA). The Mann–
Whitney U test for nonparametric data was used for sta-
tistical analysis between the fold changes of population of 
each condition. The results were considered significant at 
P < 0.05.
Results
Analysis of leukocyte populations obtained from HSC 
culture
HSC cultures were started with highly purified CD34+ 
Lin− cells (95–98%) and maintained for 10  days. The 
expansion of total nucleated cells ranged from 5.1 to 8.5-
fold on day 5 and 16.6 to 25.15-fold on day 10 after cul-
tivation (Fig.  1a). The viability of the immune cells was 
more than 90% over the cultivation period (Fig. 1b).
Populations of leukocytes in the HSC cultures were 
characterized by flow cytometry on day 10 post in vitro 
cultivation. Several types of immune cell (Fig.  1c) were 
observed, CD3+ T lymphocytes (20.96% ±1.33), B lym-
phocytes (7.47%  ±0.80), monocytes (10.64%  ±0.72), 
dendritic cells (5.28%  ±0.72), natural killer cells 
(1.88%  ±0.31), natural killer T cells (6.18%  ±1.17) and 
granulocytes (25.65% ±1.94) (examined by Giemsa stain-
ing). The rest were CD34+ HSC (21.94% ±2.57) remain-
ing in the culture. Taken together (Fig. 1d), mononuclear 
cells (52.4%  ±2.26) were the majority of immune cells 
in this HSC culture giving twofold higher numbers than 
that of the polymorphonuclear cells (25.6% ±1.94).
Alterations of lymphocyte population by an in vitro 
exposure to malaria parasites
An inhibitory effect of Plasmodium to the newly pro-
duced T lymphocytes was observed in the in  vitro cul-
ture system (Fig.  2). Both intact PfIEs and PfIEs lysates 
significantly reduced (P  ≤  0.001) CD4+ T lymphocytes 
by 0.35 ± 0.12 and 0.45 ± 0.11-fold, respectively (Fig. 2a). 
Only intact PfIEs could deplete half of CD8+ T lympho-
cytes (P ≤ 0.05) (Fig. 2B). Neither antigen from P. vivax 
(
Fold change of population
=
Percentage population of each condition
Percentage population of media
)
Page 4 of 10Chitsanoor et al. Malar J  (2017) 16:131 
showed any significant effect on either CD4+ or CD8+ 
T lymphocytes compared to their corresponding unin-
fected erythrocytes control (UIEs). The mitogenic effect 
of PHA was also observed, showing a 1.4  ±  0.18-fold 
increases of CD4+ T lymphocytes, whereas CD8+ T lym-
phocytes were not affected in the HSC culture (Fig. 2b).
The influence of Plasmodium to the transitional stages 
of T lymphocytes (CD3+4−8− cells and CD3+4+8+ 
cells) was monitored in this HSCs culture system. Dou-
ble positive T lymphocytes (CD3+4+8+ cells) increased 
2.5 ±  0.79-fold in the presence of PfIEs lysates (Fig. 2c) 
whereas double negative T lymphocytes (CD3+4−8− 
cells) were elevated 1.6  ±  0.13-fold when exposed to 
PvIEs lysates compared to UIEs (Fig.  2D) (scatter plots 
and absolute number of T lymphocyte, can be viewed in 
Additional files 2 and 3).
Plasmodium falciparum induced expression of CD95 on the 
surface membrane of T lymphocytes
Depletion of T lymphocytes by the malaria parasite was 
associated with apoptosis through the CD95 pathway. 
Abundant CD8 T lymphocytes expressing CD95 on 
their surface were found on day 2 after being exposed 
to both intact PfIEs (3.69 ±  0.21-fold) and PfIEs lysates 
(2.15 ± 0.16-fold). CD4 T lymphocytes expressing CD95 
were increased slightly in co-cultivation with intact PfIEs 
(1.52 ± 0.21-fold) compared to all other antigens in this 
study (Additional file 3). Plasmodium vivax did not sig-
nificantly induce the expression of CD95 on T lympho-
cytes compared to UIEs (Fig.  3) (scatter plots can be 
viewed in Additional file 4).
The diverse effects of Plasmodium falciparum 
and Plasmodium vivax on antigen presenting cells
The effects of malaria parasites on monocytes and den-
dritic cells were assessed (Fig.  4). PfIEs lysates signifi-
cantly (P ≤ 0.05) increased the number of HSC-derived 
monocytes by 2.14 ± 0.78-fold when compared to UIEs 
lysates. Intact PfIEs did not affect the monocyte popu-
lation but reduced by more than half HSC-derived den-
dritic cells (0.45  ±  0.09) compared to the intact UIEs 
(P  ≤0.05). Neither intact IEs nor the IEs lysates of P. 
Fig. 1 Growth, viability and differentiation of cells from CD34+ HSCs in vitro prior exposure to malaria antigens. CD34+Lin− cells were isolated 
using a CD34 isolation kit and cultured in StemlinII™ medium supplemented with suitable growth factors for 10 days. The differentiated leukocytes 
derived from HSCs were characterized by flow cytometry. The data shown in bar graphs represent cell growth (a), and viability (b) over 10 days 
(Mean ± SD), with the data being obtained from ten individual cord blood samples. The pie charts show the cell population found on day 10 of HSC 
cultures using flow cytometry characterizations (c), and the relative number of cells in the three groups; mononuclear cell, polymorphonuclear cell 
and haematopoietic stem cell (d) (% of total cells). The data are mean values obtained from ten individual cord blood samples
Page 5 of 10Chitsanoor et al. Malar J  (2017) 16:131 
Fig. 2 Responses of naïve T lymphocytes to malaria parasites. HSCs-derived mononuclear cells (10 days old) were co-cultured with malaria antigens 
in various forms and uninfected erythrocyte controls. The bar graphs represent the fold changes of T lymphocytes sub-populations after 4 days of 
co-culture with the malaria antigens. CD3+4+8− cells (a), CD3+4−8+ cells (b), CD3+4+8+ cells (c), and CD3+4−8− cells (d) with standard deviations. 
The data are mean values obtained from five individual cord blood samples. *P ≤ 0.05, ***P ≤ 0.001, int.PfIEs intact P. falciparum-infected erythro-
cytes, int.PvIEs intact P. vivax-infected erythrocytes, int.UIEs intact uninfected erythrocytes, lys.PfIEs cell lysate from P. falciparum-infected erythrocytes, 
lys.PvIEs cell lysate from P. vivax-infected erythrocytes, lys.UIEs cell lysate from uninfected erythrocytes, PHA phytohemagglutinin
Fig. 3 Malaria parasites induce the expression of CD95 on T lymphocytes. HSCs-derived mononuclear cells (10 days old) were co-cultured with 
malaria antigens in various forms and uninfected erythrocyte controls. The bar graphs show the fold changes of CD95+ T lymphocyte population 
after co-culture with the malaria parasite for 2 days, CD3+4+ (a) and CD3+8+ T lymphocytes (b) with standard deviation. The data are mean values 
obtained from five individual cord blood samples. *P ≤ 0.05
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vivax showed any effect on monocytes or dendritic cells 
(scatter plots, can be viewed in Additional file 5).
Malaria parasites altered the expression of human 
leucocyte antigen (HLA)‑DR on the surface of monocytes 
and dendritic cells
To observe any modulation of antigen presenting cells 
by the malaria parasites, the level of HLA-DR expression 
by monocytes and dendritic cells was measured. Flow 
cytometric analysis showed that intact PfIEs increased 
HLA-DR expression by twofold as shown by increased 
mean fluorescence intensity (MFI) on the surface of 
monocytes (CD14+ cells). In contrast, intact PvIEs com-
pared with intact UIEs did not show any difference on the 
overall level of HLA-DR as indicated by the MFI values 
(12.6 and 14.8, respectively); nonetheless the patterns of 
HLA-DR expression on CD14+ cells under the influence 
of P. vivax antigens were noticeably different compared 
to that of CD40+ cells (Fig. 5). The IEs lysates from both 
P. falciparum (MFI  =  38.2) and P. vivax (MFI  =  32.1) 
Fig. 4 Effects of malaria parasites on the antigen presenting cells. HSCs-derived mononuclear cells (10 days old) were co-cultured with malaria 
antigens in various forms and uninfected erythrocyte controls. The bar graphs show the fold change of antigen presenting cell populations after co-
culture with the malaria parasite for 4 days, monocytes (a), and dendritic cells (b) with standard deviation. The data are mean values obtained from 
five individual cord blood samples. *P ≤0.05
Fig. 5 Effects of malaria parasites on HLA-DR expression of antigen presenting cells. HSCs-derived mononuclear cells (10 days old) were co-cul-
tured with malaria antigens in various forms and uninfected erythrocyte controls. The dark gray histograms represent the level of HLA-DR expres-
sion on the surface of the CD14+ cells, and CD40+ cells. The light gray histograms represent isotype controls after co-culture in the presence of the 
malaria parasite antigens for 4 days. Data are shown as mean fluorescence intensity (MFI) obtained from a selected cord blood representing the 
group
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parasites also showed twofold higher HLA-DR expres-
sion than that of UIEs lysates (MFI = 16.2).
In dendritic cells, the intact PfIEs (MFI  =  12.8) 
reduced HLA-DR expression by half while intact PvIEs 
(MFI =  24.4) did not reduce in comparison with intact 
UIEs (MFI = 22.4). However, PfIEs lysates (MFI = 46.2) 
and PvIEs lysates (MFI  =  30.3) increased the levels of 
HLA-DR by twofold and 1.5-fold, respectively, on these 
cells compared to that of UIEs lysates (Fig. 5).
Plasmodium falciparum sustained existence of CD34+ HSCs 
in the culture
The effect of malaria parasites on the development of 
HSCs is not well understood. Results obtained from the 
in vitro model presented in this study showed that intact 
PfIEs significantly increased the CD34+ HSCs remain-
ing in the culture, resulting in a 1.5  ±  0.24-fold higher 
abundance of these cells when compared to the control 
(Fig. 6). All other antigens tested did not alter the num-
ber of CD34+ HSCs in the cultures (scatter plots, can be 
viewed in Additional file 6).
Discussion
The development of an in  vitro model for HSC-derived 
MNCs with minimal cytokine supplementation (SCF, 
IL-3, transferrins and human insulin) [8] generating naïve 
mononuclear cells is crucial to the study of the response 
of newly produced immune cells to any agent. Such a sys-
tem eliminates problems frequently encountered when 
using PBMCs from donors with various immunological 
profiles. In the HSC-derived MNC culture, phenotypic 
markers of mature leukocyte populations were variously 
expressed on consecutive days as reported previously [7]. 
On day 10 of cultivation, the expression of all mature leu-
kocytes markers was observed with sufficient cell num-
bers to perform the experiment. The high percentage of 
monocytes and dendritic cells obtained under these cul-
ture conditions was an additional factor favouring the use 
of HSC-derived MNCs to study the responses of naïve 
immune cells to an infection. The activation of newly 
produced T lymphocytes by malaria antigens was verified 
by showing up-regulation of an activation marker, CD25 
(IL2 receptor) (more view in Additional file 7). This study 
shows an alternative model to follow the responses of 
naïve lymphocytes to P. falciparum and P. vivax malaria.
Immunity to malaria relies on T lymphocytes as the 
agents for combating malaria parasites in both the pre-
erythrocytic and erythrocytic stages [9–11]. However, 
understanding the mechanism or function of these cells 
is not yet complete. In the study presented here, P. falci-
parum depleted T lymphocytes in accordance with previ-
ous studies [12, 13], although some previous studies have 
also shown lymphopaenia in P. vivax patients [14]. Dif-
ferent mechanisms for the suppression of T lymphocytes 
by malaria parasites have been proposed, and two possi-
ble hypotheses could explain lymphopaenia during acute 
malaria infection. Firstly the distribution of activated 
T lymphocyte to other organs such as spleen has been 
reported in mice [15] although this phenomenon could 
not be observed in this in  vitro system. Secondly, the 
depletion of T lymphocyte observed in this experiment 
could occur as a result of the induction of T lymphocyte 
apoptosis upon malaria parasite infection.
Apoptosis is suggested to be associated with lympho-
paenia through various mechanisms during acute infec-
tion [16, 17]. The data showed that P. falciparum but 
not P. vivax caused the loss of CD4 and CD8 positive 
T cells and these were associated with the CD95 (Fas)-
ligand binding pathway. Our unpublished data indicated 
that CD95 appeared on lymphocytes after the cells were 
exposed to P. falciparum antigens from day 2 onward and 
these cells were undetectable on day 4. Therefore CD95 
was determined on day 2 whereas other population mark-
ers were done on day 4. Plasmodium falciparum affected 
the expression of CD95 of the CD8+ subpopulation more 
than that of CD4+ lymphocytes. However, a study in 
murine malaria showed that depletion of parasite-spe-
cific T cells was not via the Fas pathway [18]. Therefore, 
the present findings confirmed previous report on the 
difference in immune modulatory roles between human 
and murine malaria.
In this study, parasite antigens were obtained from 
different sources, namely P. falciparum obtained from 
in  vitro culture and P. vivax isolated from endemically 
Fig. 6 Effects of malaria on the remaining of CD34+ cells. HSCs-
derived mononuclear cells (10 days old) were co-cultured with 
malaria antigens in various forms and uninfected erythrocyte con-
trols. The bar graph shows the fold changes of CD34+ cells remaining 
in the culture after co-culture with the malaria parasite antigens for 
4 days, with standard deviation. The data are mean values obtained 
from five individual cord blood samples. *P ≤ 0.05
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infected people with a short period of culture to reach 
schizont stage. The endogenous RBC membrane com-
ponents should be the same, and the obvious difference 
is the membrane associated parasite proteins. Therefore, 
the difference in the source of parasites should not affect 
the study outcome, but the difference in species of para-
sites would play major role in the activation of the naïve 
immune cells. The results showed the response of HSCs 
derived T lymphocytes exposed to P. falciparum have a 
higher degree of immune suppression as compared to P. 
vivax in term of amount and polymorphism of proteins 
[19–21]. The antigenicity of malaria proteins depends on 
the nature of the proteins and the process of presenta-
tion by antigen presenting cells. In this study, particulate 
infected erythrocytes (intact IEs) of both parasites could 
alter the population of HLA−DR+ cells to a greater extent 
than the parasite lysates. Differential responses of T lym-
phocytes to different forms of antigen have been docu-
mented previously [22, 23].
Malaria infection can suppress erythropoiesis [24, 25], 
but little is known about the influence on immune cells in 
the biological niches where development and differentia-
tion take place, i.e. the bone marrow, spleen and lymph 
nodes. However, a modulatory effect of malaria on the 
alteration of immune cell populations was demonstrated 
in this in vitro model. The double-positive developmental 
stage of T lymphocytes (CD3+CD4+CD8+) was elevated 
upon exposure to cell lysates of P. falciparum. This phe-
nomenon could be associated with the severity of malaria 
as has been reported for several other infectious diseases, 
such as HIV [26] and Chagas disease [27], including auto-
immune diseases [28] suggesting an immune suppressive 
role of this cell type [29]. On the other hand, the incre-
ment of double-negative developmental stage of T lym-
phocytes (CD3+CD4−CD8−) when activated with cell 
lysates of the P. vivax malaria parasite, emphasized the 
difference in the response of newly produced immune 
cells to the two parasites. Therefore, the consequence of 
elevated numbers of double-positive and double-nega-
tive T lymphocytes upon exposure to proteins extracted 
from P. falciparum and P. vivax, respectively, observed 
here is interesting and deserves further investigation for 
their roles in immunity to malaria. This study showed for 
the first time that P. falciparum and P. vivax differently 
modulate lymphopoiesis during the immune response to 
malaria.
Immunity to malaria requires functional co-operation 
between antigen-presenting cells (macrophages and den-
dritic cells) and lymphocytes [30, 31], but these antigen-
presenting cells can occasionally play a role in severe 
malaria [32]. In this study, cell lysates from P. falciparum 
raised the proportion of monocytes in the HSC culture 
which might be associated with the immunopathology of 
severe malaria. Signs of defective immune priming were 
also seen in this study, as shown by a decrease in the pop-
ulation of professional antigen presenting cells, dendritic 
cells, after exposure to P. falciparum while the number of 
these antigen presenting cells was similar to control cul-
tures after exposure to P. vivax. In addition, the opposite 
effects of P. falciparum and P. vivax on the expression 
of HLA-DR in monocytes and dendritic cells described 
here supports previous findings reported by others [33]. 
Interestingly, the two types of antigen from P. falciparum 
increased expression of HLA-DR on the surface of mono-
cytes which could be an incidence of severe outcome 
from immune over activation as reported in autoimmune 
disease patients [34]. In contrast, antigens from P. vivax 
regulated the distinctive pattern of HLA-DR expression 
on these monocytes which could confer milder symp-
toms as compared to those caused by P. falciparum.
The effect of human malaria on the development of 
HSCs is not known and whether the prolonged CD34+ 
HSC propagation in  vitro was due mainly to activation 
by P. falciparum-infected erythrocytes requires further 
investigation.
Conclusion
These finding suggest that immunosuppression by 
malaria infection possibly takes place at an early stage 
of lymphocyte maturation. In addition, the use of naïve 
mononuclear cells derived from HSC as an in vitro model 
for research in immunity can be easily implemented and 
would reduce the discrepancy of mononuclear cell qual-
ity between different studies.
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